Geomatys’ innovation project continues to evolve! Our team of infectious disease experts, geospatial intelligence engineers, and performance-focused software developers is laying the groundwork to bring disease risk forecasting from the pages to the street. We are partnering with some of the best researchers from around the globe to provide vetted information, with our sights set on making access equitable and sustainable.
We have made significant progress towards creating a first version of our platform, on which we are implementing a risk model for a key emerging disease of high consequence. We also have been exploring ways to increase the scalability of both our technical tools and our commercial activity. The market appears to be developing, with new actors entering the field, but our edge defined by the union of long-standing domain and technical expertise remains sharp with an industry-focused strategy to enlarge the impact of the innovations.